Source: Eur Respir Monogr 2013; 59: 13-27
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Peter J. Barnes. COPD: inflammatory mechanisms and systemic consequences. Eur Respir Monogr 2013; 59: 13-27

Member's Comments

No comment yet.

Related content which might interest you: Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Source: Eur Respir J 2008; 31: 1334-1356 Year: 2008 The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Implications for disease and therapy Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD Year: 2005 Carbonyl stress and enhanced macrophage function Source: Annual Congress 2005 - Oxidative and nitrative stress: control of cell function in COPD Year: 2005 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 The role of inflammation in COPD Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Leptin in relation to systemic inflammation and regulation of the energy balance Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=56 Year: 2003 Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Systemic effects of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224 Year: 2006 Rosuvastatin effects on systemic inflammation, oxidative stress and antioxidants in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD diagnosis and management Year: 2016 Interstitial lung disease induced by exogenous agents: factors governing susceptibility Source: Eur Respir J 2001; 18: 30S-42S Year: 2001 Autoimmunity and pulmonary hypertension: a perspective Source: Eur Respir J 2005; 26: 1110-1118 Year: 2005 Development of new treatments for complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and metabolic syndrome (MetS) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Resolution of inflammation in airway diseases Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Systemic inflammation and systemic oxidative stress in acute COPD exacerbation Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Chronic obstructive pulmonary disease: molecular and cellularmechanisms Source: Eur Respir J 2003 Oct 01;22(4):672-688 Year: 2003 Nitrosative and cytokine status in patients with COPD and chronic cerebrovascular diseases (CCVD) Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011